Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 17.39% is 24% above its 5-year average of 13.97%, near the high end of its 5-year range (-46.82%–19.97%).
1.09% above its 12-month average of 17.20%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 17.33%.
EBITDA MARGIN
17.39%
EBITDA MARGIN AVG TTM
17.20%
EBITDA MARGIN AVG 3Y
15.08%
EBITDA MARGIN AVG 5Y
13.97%
EBITDA MARGIN AVG 10Y
10.58%
EBITDA MARGIN AVG 15Y
16.08%
EBITDA MARGIN AVG 20Y
15.36%
CURRENT VS TTM AVG
+1.09%
CURRENT VS 3Y AVG
+15.30%
CURRENT VS 5Y AVG
+24.49%
CURRENT VS 10Y AVG
+64.37%
CURRENT VS 15Y AVG
+8.15%
CURRENT VS 20Y AVG
+13.20%
Market Cap
$4.15B
EBITDA Margin
-250.61%
TTM Avg
-502.94%
3Y Avg
-374.26%
5Y Avg
-228.13%
Market Cap
$4.15B
EBITDA Margin
-1948.43%
TTM Avg
-2807.95%
3Y Avg
-7106.81%
5Y Avg
-6733.51%
Market Cap
$4.30B
EBITDA Margin
-31.52%
TTM Avg
-36.86%
3Y Avg
-49.55%
5Y Avg
-49.55%
Market Cap
$4.44B
EBITDA Margin
23.00%
TTM Avg
14.06%
3Y Avg
2.00%
5Y Avg
2.94%
Market Cap
$4.46B
EBITDA Margin
-14.19%
TTM Avg
-47.13%
3Y Avg
-77.82%
5Y Avg
-97.39%
Market Cap
$4.65B
EBITDA Margin
9.15%
TTM Avg
-7.04%
3Y Avg
-33.99%
5Y Avg
-33.99%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LivaNova PLC (LIVN) | $4.16B | 17.39% | 17.20% | 15.08% | 13.97% |
| AbCellera Biologics Inc. (ABCL)vs › | $4.15B | -250.61% | -502.94% | -374.26% | -228.13% |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.15B | -1948.43% | -2807.95% | -7106.81% | -6733.51% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.30B | -31.52% | -36.86% | -49.55% | -49.55% |
| ICU Medical, Inc. (ICUI)vs › | $3.98B | 14.57% | 8.24% | 9.01% | 11.36% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.36B | N/A | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.44B | 23.00% | 14.06% | 2.00% | 2.94% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.46B | -14.19% | -47.13% | -77.82% | -97.39% |
| BillionToOne, Inc. (BLLN)vs › | $4.65B | 9.15% | -7.04% | -33.99% | -33.99% |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 7.23% | 7.47% | 7.86% | 7.54% |
Gross Margin
68.2%
EBITDA Margin
17.4%
Operating Margin
13.5%
Net Margin
12.8%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 17.33% |
| 2026-03-31 | 18.71% |
| 2025-12-31 | 11.82% |
| 2025-09-30 | 18.52% |
| 2025-06-30 | 19.64% |
| 2025-03-31 | 19.97% |
| 2024-12-31 | 15.41% |
| 2024-09-30 | 15.32% |
| 2024-06-30 | 16.47% |
| 2024-03-31 | 9.96% |
| 2023-12-31 | -23.25% |
| 2023-09-30 | 6.83% |
| 2023-06-30 | 11.00% |
| 2023-03-31 | 4.79% |
| 2022-12-31 | 10.58% |
| 2022-09-30 | -46.82% |
| 2022-06-30 | 18.09% |
| 2022-03-31 | 10.10% |
| 2021-12-31 | 14.07% |
| 2021-09-30 | 12.83% |
| 2021-06-30 | -7.51% |
| 2021-03-31 | 2.86% |
| 2020-12-31 | -87.54% |
| 2020-09-30 | 7.74% |
| 2020-06-30 | 2.26% |
| 2020-03-31 | 16.54% |
| 2019-12-31 | -42.68% |
| 2019-09-30 | 17.63% |
| 2019-06-30 | -2.37% |
| 2019-03-31 | -1.56% |
| 2018-12-31 | -87.44% |
| 2018-09-30 | 4.46% |
| 2018-06-30 | 13.81% |
| 2018-03-31 | 11.82% |
| 2017-12-31 | 9.63% |
| 2017-09-30 | 17.53% |
| 2017-06-30 | 16.17% |
| 2017-03-31 | 0.55% |
| 2016-12-31 | -8.02% |
| 2016-09-30 | 15.40% |
| 2016-06-30 | 12.49% |
| 2016-03-31 | -4.36% |
| 2015-10-18 | -35.94% |
| 2015-09-30 | 28.09% |
| 2015-04-30 | 26.33% |
| 2015-01-31 | 34.87% |
| 2014-10-31 | 37.75% |
| 2014-07-31 | 32.73% |
| 2014-04-30 | 33.23% |
| 2014-01-31 | 33.06% |
| 2013-10-31 | 33.15% |
| 2013-07-31 | 21.72% |
| 2013-04-30 | 31.69% |
| 2013-01-31 | 34.39% |
| 2012-10-31 | 33.94% |
| 2012-07-31 | 30.49% |
| 2012-04-30 | 35.03% |
| 2012-01-31 | 31.78% |
| 2011-10-31 | 29.62% |
| 2011-07-31 | 23.27% |
| 2011-04-30 | 26.88% |
| 2011-01-31 | 26.38% |
| 2010-10-31 | 28.45% |
| 2010-07-31 | 27.37% |
| 2010-04-30 | 26.96% |
| 2010-01-31 | 23.53% |
| 2009-10-31 | 23.59% |
| 2009-07-31 | 18.20% |
| 2009-04-30 | 17.42% |
| 2009-01-31 | 16.85% |
| 2008-10-31 | 13.53% |
| 2008-07-31 | 10.76% |
| 2008-04-30 | 11.36% |
| 2008-01-31 | 4.43% |
| 2007-10-31 | -8.89% |
| 2007-07-31 | -23.54% |
| 2007-04-30 | -28.76% |
| 2007-01-31 | -55.59% |
| 2006-10-31 | -32.54% |
| 2006-07-31 | -21.60% |
| 2006-04-30 | -7.93% |
| 2006-01-31 | -42.43% |
| 2005-10-31 | -70.93% |
| 2005-07-31 | -66.55% |
| 2005-04-30 | -21.96% |
| 2005-01-31 | -0.51% |
| 2004-10-31 | -4.17% |
| 2004-07-31 | -7.44% |
| 2004-04-30 | 1.28% |
| 2004-01-31 | 85.42% |
| 2003-10-31 | 17.43% |
| 2003-07-31 | 14.52% |
| 2003-04-30 | 19.19% |
| 2003-01-31 | 17.76% |
| 2002-10-31 | 9.18% |
| 2002-07-31 | -12.22% |
